Compared to controls, patients with NAFLD/NASH exhibit elevated levels of hepatic GSDMD and GSDMD-NT proteins, with particularly heightened expression of GSDMD-NT observed in those with NASH. The gene discussed is GSDMD; the disease is metabolic dysfunction-associated steatohepatitis.